Related Experiment Videos
Identification, localization and characterization of the human gamma-synuclein gene
C Lavedan1, E Leroy, A Dehejia
1Laboratory of Genetic Disease Research, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Human Genetics
|September 16, 1998
Summary
Researchers identified gamma-synuclein (SNCG), a protein homologous to alpha-synuclein linked to Parkinson's disease. This gene is expressed in the brain and potentially overexpressed in certain cancers.
Area of Science:
- Genetics
- Neuroscience
- Oncology
Background:
- The human synuclein gene family includes alpha-synuclein and beta-synuclein.
- Alpha-synuclein mutations are associated with Parkinson's disease.
- Gamma-synuclein (SNCG) is a newly identified member of this family.
Purpose of the Study:
- To identify and characterize the gamma-synuclein (SNCG) gene.
- To determine the genomic sequence and structure of SNCG.
- To investigate the expression patterns and potential roles of SNCG.
Main Methods:
- Gene identification and characterization.
- Genomic sequencing.
- Exon sequence analysis.
- Gene expression analysis using EST database.
Main Results:
- Identified and characterized gamma-synuclein (SNCG), a 127 amino acid protein.
- SNCG is highly homologous to alpha- and beta-synuclein.
- SNCG gene is located on chromosome 10q23 and primarily expressed in the brain, including the substantia nigra.
- SNCG (BCSG1) is overexpressed in advanced breast carcinoma and potentially in ovarian tumors.
Conclusions:
- Gamma-synuclein (SNCG) is a novel synuclein family member with structural similarity to alpha-synuclein.
- SNCG expression is predominantly in the brain, suggesting a role in neurological functions.
- Aberrant SNCG expression in cancers indicates its potential involvement in tumorigenesis.